Showing results 10 to 17 of 17
< previous
Issue Date | Title | Author(s) |
2021 | Immunotherapy for Alzheimer's Disease: Current Scenario and Future Perspectives. | Usman, MB; Bhardwaj, S; Roychoudhury, S; Kumar, D; Alexiou, A; Kumar, P; Ambasta, RK; Prasher, P; Shukla, S; Upadhye, V; Khan, FA; Awasthi, R; Shastri, MD; Singh, SK; Gupta, G; Chellappan, DK; Dua, K; Jha, SK; Ruokolainen, J; Kesari, KK; Ojha, S; Jha, NK |
2022-03 | Molecular mechanisms of developmental pathways in neurological disorders: a pharmacological and therapeutic review | Jha, NK; Chen, W-C; Kumar, S; Dubey, R; Tsai, L-W; Kar, R; Jha, SK; Gupta, PK; Sharma, A; Gundamaraju, R; Pant, K; Mani, S; Singh, SK; Maccioni, RB; Datta, T; Singh, SK; Gupta, G; Prasher, P; Dua, K; Dey, A; Sharma, C; Mughal, YH; Ruokolainen, J; Kesari, KK; Ojha, S |
2021-10 | Nanotechnology-based therapeutic formulations in the battle against animal coronaviruses: an update | Krishnan, S; Thirunavukarasu, A; Jha, NK; Gahtori, R; Roy, AS; Dholpuria, S; Kesari, KK; Singh, SK; Dua, K; Gupta, PK |
- | Phytomedicines Targeting Cancer Stem Cells: Therapeutic Opportunities and Prospects for Pharmaceutical Development | Gupta, PK; Saraff, M; Gahtori, R; Negi, N; Tripathi, SK; Kumar, J; Kumar, S; Aldhayan, SH; Dhanasekaran, S; Abomughaid, MM; Dua, K; Gundamaraju, R; Ojha, S; Ruokolainen, J; Jha, NK; Kesari, KK |
2022-02-23 | Re-establishing the comprehension of phytomedicine and nanomedicine in inflammation-mediated cancer signaling. | Jha, NK; Arfin, S; Jha, SK; Kar, R; Dey, A; Gundamaraju, R; Ashraf, GM; Gupta, PK; Dhanasekaran, S; Abomughaid, MM; Das, SS; Singh, SK; Dua, K; Roychoudhury, S; Kumar, D; Ruokolainen, J; Ojha, S; Kesari, KK |
- | Recent Advances in Cardiac Tissue Engineering for the Management of Myocardium Infarction | Sharma, V; Dash, SK; Govarthanan, K; Gahtori, R; Negi, N; Barani, M; Tomar, R; Chakraborty, S; Mathapati, S; Bishi, DK; Negi, P; Dua, K; Singh, SK; Gundamaraju, R; Dey, A; Ruokolainen, J; Thakur, VK; Kesari, KK; Jha, NK; Gupta, PK; Ojha, S |
- | Synthesis, in Silico Study, and Anti-Cancer Activity of Thiosemicarbazone Derivatives | Sibuh, BZ; Gupta, PK; Taneja, P; Khanna, S; Sarkar, P; Pachisia, S; Khan, AA; Jha, NK; Dua, K; Singh, SK; Pandey, S; Slama, P; Kesari, KK; Roychoudhury, S |
- | The FBXW7‐NOTCH interactome : A ubiquitin proteasomal system‐induced crosstalk modulating oncogenic transformation in human tissues | Kar, R; Jha, SK; Ojha, S; Sharma, A; Dholpuria, S; Raju, VSR; Prasher, P; Chellappan, DK; Gupta, G; Singh, S; Paudel, KR; Hansbro, PM; Singh, S; Ruokolainen, J; Kesari, KK; Dua, K; Jha, NK |